MedPath

Diabetes, Falls, and Fractures

Completed
Conditions
Small Fiber Neuropathy
Diabetic Peripheral Neuropathy
Vestibular Neuropathy
Autonomic Neuropathy, Diabetic
Balance; Distorted
Muscle Weakness
Sarcopenia
Diabetes
Interventions
Diagnostic Test: Quantative Sensory Testing
Diagnostic Test: NCStat-DPN-Check
Diagnostic Test: Composite Autonomic Symptom Score 31
Diagnostic Test: Computerized dynamic posturography
Diagnostic Test: Video Head Impulse Test
Diagnostic Test: Accelerometer
Diagnostic Test: Handgrip strength
Diagnostic Test: Dual Energy X-ray Absorbtimetry scan
Diagnostic Test: Force Plate Platform
Registration Number
NCT05389566
Lead Sponsor
Aalborg University Hospital
Brief Summary

Comparing severity of diabetic peripheral neuropathy (small and large fibers including autonomic neuroapthy) to postural control and vestibular measurements

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
110
Inclusion Criteria
  1. Men and women with minimum 40 years of age and maximum 70 years of age.
  2. Diagnosis of T1D or T2D
  3. Diagnosis of diabetes with at least one year prior to inclusion of the study
  4. Signed the informed consent.
Exclusion Criteria
  1. Severe decreased liver function (Alanin amino-transaminase (ALAT)>250u/l, GammaGlutamyltransferase (GGT)>150u/l)

  2. Moderate to severe kidney dysfunction, estimated Glomerular Filtration Rate (eGFR) <15mmol/L/1,73m2

  3. Pregnancy or breast feeding

  4. Active malignancy or terminal ill.

  5. Current or previous alcohol- or drug abuse

  6. Not being able to understand Danish written and/or verbally 9. Terms according to investigators judgement that makes subjects unsuitable to participate including lack of understanding or reduced physical ability. 10. Participating in other clinical studies 11. Maximum of 10 hours of weekly exercise.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Type 1 diabetesAccelerometerPeople with type 1 diabetes above 40 years
Type 1 diabetesHandgrip strengthPeople with type 1 diabetes above 40 years
Type 1 diabetesDual Energy X-ray Absorbtimetry scanPeople with type 1 diabetes above 40 years
People with type 2 diabetesQuantative Sensory TestingPeople with type 2 diabetes above 50 years
People with type 2 diabetesNCStat-DPN-CheckPeople with type 2 diabetes above 50 years
Healthy controlsComposite Autonomic Symptom Score 31Healthy controls without diabetes
Healthy controlsVideo Head Impulse TestHealthy controls without diabetes
Healthy controlsAccelerometerHealthy controls without diabetes
Healthy controlsHandgrip strengthHealthy controls without diabetes
People with type 2 diabetesComputerized dynamic posturographyPeople with type 2 diabetes above 50 years
People with type 2 diabetesVideo Head Impulse TestPeople with type 2 diabetes above 50 years
Type 1 diabetesComputerized dynamic posturographyPeople with type 1 diabetes above 40 years
Type 1 diabetesVideo Head Impulse TestPeople with type 1 diabetes above 40 years
Type 1 diabetesQuantative Sensory TestingPeople with type 1 diabetes above 40 years
Type 1 diabetesComposite Autonomic Symptom Score 31People with type 1 diabetes above 40 years
People with type 2 diabetesComposite Autonomic Symptom Score 31People with type 2 diabetes above 50 years
Type 1 diabetesNCStat-DPN-CheckPeople with type 1 diabetes above 40 years
Type 1 diabetesForce Plate PlatformPeople with type 1 diabetes above 40 years
People with type 2 diabetesAccelerometerPeople with type 2 diabetes above 50 years
People with type 2 diabetesDual Energy X-ray Absorbtimetry scanPeople with type 2 diabetes above 50 years
Healthy controlsComputerized dynamic posturographyHealthy controls without diabetes
Healthy controlsForce Plate PlatformHealthy controls without diabetes
People with type 2 diabetesHandgrip strengthPeople with type 2 diabetes above 50 years
Healthy controlsNCStat-DPN-CheckHealthy controls without diabetes
People with type 2 diabetesForce Plate PlatformPeople with type 2 diabetes above 50 years
Healthy controlsQuantative Sensory TestingHealthy controls without diabetes
Healthy controlsDual Energy X-ray Absorbtimetry scanHealthy controls without diabetes
Primary Outcome Measures
NameTimeMethod
Co-existence of peripheral- and vestiubular neuropathy in people with diabetesthrough study completion, an average of 2 years

Vestibular neuropathy (measured by pathological video head impulse test (v-Hit) (one-sided, two-sided or specific arcways)) will be compared with peripheral neuropathy (measured by quantitative sensory testing, nerve conduction and COMPASS-33) in the population with diabetes.

Co-existence of peripheral neuropathy and impaired dynamic postural control in people with diabetesthrough study completion, an average of 2 years

Dynamic balance (measured by Bertec) will be compared with peripheral neuropathy (measured by quantitative sensory testing, nerve conduction and COMPASS-33) in the population with diabetes.

Secondary Outcome Measures
NameTimeMethod
Correlation between the severity of peripheral neuropathy and the severity of vestibular in terms of degree of pathological video head impulse testingneuropathythrough study completion, an average of 2 years

QST / NC-Stat DPNCheck vs v-Hit

The impact of peripheral neuropathy on postural control (In quite stance)through study completion, an average of 2 years

QST / Correlation between muscle strength and peripheral neuropathy vs Force Plate

Correlation between distal neuropathy and dynamic postural control (including patterns)through study completion, an average of 2 years

QST / NC-Stat DPNCheck vs accelerometer / Bertec

Trial Locations

Locations (1)

Aalborg University Hospital

🇩🇰

Aalborg, Denmark

© Copyright 2025. All Rights Reserved by MedPath